Rehman, S.; Farhan, M.; Sarfraz, M.R.; Naveed, A.; Usman, F.; Bibi, A.; Ahmed, R.; Huq, H.; Hasan, A.; Anzoom, J.;
et al. Randomized Clinical Trial for the Optimization of Dyslipidemia Management in Patients with End-Stage Renal Disease Undergoing In-Hospital Maintenance Hemodialysis Therapy. Pharmaceutics 2025, 17, 1128.
https://doi.org/10.3390/pharmaceutics17091128
AMA Style
Rehman S, Farhan M, Sarfraz MR, Naveed A, Usman F, Bibi A, Ahmed R, Huq H, Hasan A, Anzoom J,
et al. Randomized Clinical Trial for the Optimization of Dyslipidemia Management in Patients with End-Stage Renal Disease Undergoing In-Hospital Maintenance Hemodialysis Therapy. Pharmaceutics. 2025; 17(9):1128.
https://doi.org/10.3390/pharmaceutics17091128
Chicago/Turabian Style
Rehman, Sadia, Muhammad Farhan, Muhammad Raza Sarfraz, Asma Naveed, Fahad Usman, Anila Bibi, Raheel Ahmed, Hiya Huq, Ali Hasan, Jarin Anzoom,
and et al. 2025. "Randomized Clinical Trial for the Optimization of Dyslipidemia Management in Patients with End-Stage Renal Disease Undergoing In-Hospital Maintenance Hemodialysis Therapy" Pharmaceutics 17, no. 9: 1128.
https://doi.org/10.3390/pharmaceutics17091128
APA Style
Rehman, S., Farhan, M., Sarfraz, M. R., Naveed, A., Usman, F., Bibi, A., Ahmed, R., Huq, H., Hasan, A., Anzoom, J., & Kumar, P.
(2025). Randomized Clinical Trial for the Optimization of Dyslipidemia Management in Patients with End-Stage Renal Disease Undergoing In-Hospital Maintenance Hemodialysis Therapy. Pharmaceutics, 17(9), 1128.
https://doi.org/10.3390/pharmaceutics17091128
